UnknownNCT01695512

Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patients

Studying Aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Heidelberg University
Principal Investigator
Dieter Buchheidt, MD
Medical Faculty Mannheim, University of Heidelberg
Enrollment
200 enrolled
Eligibility
18-100 years · All sexes
Timeline
20122020

Study locations (1)

Collaborators

Gilead Sciences

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01695512 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis

← Back to all trials